Investor Relations

Latest 10-K

View Latest 10-K

Stock Information


Nasdaq: ALBT




52 week Low/High

Day Low/High

Company Overview

Avalon GloboCare Corp. (NASDAQ: ALBT) is a global intelligent biotech developer and healthcare service provider dedicated to advancing cell-based technologies and therapeutics, with a focus on developing and empowering innovative and transformative cell-based technologies and their clinical applications. In addition, Avalon provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth, development, as well as competitiveness in both the domestic and global healthcare markets. Through its subsidiaries, namely GenExosome Technologies Inc. and Avactis Biosciences Inc., Avalon is establishing a leading role in the fields of exosome-based diagnostics, cellular immunotherapy (including CAR-T/CAR-NK), and regenerative medicine.

Avalon GloboCare Investor Presentation November 2022

Avalon GloboCare Investor Presentation November 2022

Download Avalon GloboCare Investor Presentation November 2022


Our people are our backbone. Touting years of experience in a variety of fields, our leadership team is the source of our success.

Investor Contact Information


Avalon GloboCare Corp.
4400 Route 9 South
Suite 3100
Freehold, NJ 07728

Investor Relations

Crescendo Communications, LLC
T: (212) 671-1020

Transfer Agent

VStock Transfer LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436